# Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

> **NCT03219372** · PHASE2 · TERMINATED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cirrhoses

## Interventions

- **DRUG:** Pravastatin Pill
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03219372
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-27
- **Primary completion:** 2018-12-04
- **Final completion:** 2019-03-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study discontinued due to low accrual.
- **Last updated:** 2021-01-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03219372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03219372, "Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03219372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*